24 results
6-K
EX-10.1
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Current report (foreign)
5:29pm
, no “Proceeding” (which for purposes of this Agreement shall mean any action, claim, suit, investigation or proceeding (including, without limitation … , an investigation or partial proceeding, such as a deposition), whether commenced or threatened) has been instituted in any such jurisdiction revoking
6-K
EX-10.1
IPA
ImmunoPrecise Antibodies Ltd
6 Dec 23
Current report (foreign)
5:19pm
Proceedings. There is no material action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental proceeding pending … , influence payment, kickback or other unlawful payment; or (vi) received notice of any investigation, proceeding or inquiry by any Governmental Entity
6-K
EX-8.1
IPA
ImmunoPrecise Antibodies Ltd
6 Dec 23
Current report (foreign)
5:19pm
. In addition, we have not made an independent investigation or audit of the facts set forth in the above referenced documents or otherwise provided to us. We
6-K
EX-10.1
IPA
ImmunoPrecise Antibodies Ltd
15 Aug 23
Current report (foreign)
5:50pm
" (which for purposes of this Agreement shall mean any action, claim, suit, investigation or proceeding (including, without limitation, an investigation … , inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any
F-3
EX-4.3
IPA
ImmunoPrecise Antibodies Ltd
10 Jul 23
Shelf registration (foreign)
7:04pm
as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based … ;
(3) a statement that, in the opinion of each such individual, he has made such examination or investigation as is necessary to enable him to express
6-K
EX-99.1
h2s5i
8 Dec 22
Immunoprecise Antibodies LTD. 6-K
8:05am
6-K
EX-99.2
iw8kkrk7z zy
14 Apr 22
Current report (foreign)
10:18am
6-K
EX-99.1
cs4i3x0xzwabkgd
31 Jan 22
Immunoprecise Antibodies LTD. 6-K
7:14am
6-K
EX-99.2
rp7ktq87
13 Oct 21
ImmunoPrecise Announces At-The-Market Facility of up to US$50 Million
5:31pm
SUPPL
9nad7f w3b91ytpgd
13 Oct 21
Supplemental materials (foreign)
5:29pm
6-K
EX-99.2
zprp3czqq9kns8b
4 Feb 21
Amended and Restated Underwriting Agreement
5:12pm
6-K
EX-99.1
bjlbe f6yd1ah
4 Feb 21
Amended and Restated Underwriting Agreement
5:12pm
SUPPL
3qubp87wleowi7d
4 Feb 21
Supplemental materials (foreign)
5:08pm
SUPPL
kwb0ygpa
3 Feb 21
Supplemental materials (foreign)
4:42pm
F-10/A
EX-7.1
12pr 1tphyf3f07k
5 Jan 21
Registration of securities (Canada) (amended)
5:29pm
40FR12B/A
EX-99.123
f4di1eewchv9an8ih0
22 Dec 20
Initial registration of securities (Canada) (amended)
11:05am
40FR12B/A
EX-99.128
dq0e9yeb65y
22 Dec 20
Initial registration of securities (Canada) (amended)
11:05am
40FR12B/A
EX-99.130
xr3 61t2s0j
22 Dec 20
Initial registration of securities (Canada) (amended)
11:05am
40FR12B/A
EX-99.127
r8127
22 Dec 20
Initial registration of securities (Canada) (amended)
11:05am
40FR12B/A
EX-99.129
jz0st
22 Dec 20
Initial registration of securities (Canada) (amended)
11:05am